Log in to search using one of your social media accounts:

 

Trizivir (Abacavir Sulfate, Lamivudine, and Zidovudine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 3, 2017 Category: Drugs & Pharmacology Source Type: news

Aurobindo Pharma gets USFDA nod for HIV drug
"The company has received final approval from the USFDA to manufacture abacavir sulfate and lamivudine tablets, 600 mg/ 300 mg." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 30, 2017 Category: Pharmaceuticals Source Type: news

EPZICOM (Abacavir Sulfate And Lamivudine) Tablet, Film Coated
Updated Date: Mar 21, 2017 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - March 21, 2017 Category: Drugs & Pharmacology Source Type: news

TRIZIVIR (Abacavir Sulfate, Lamivudine, And Zidovudine) Tablet, Film Coated
Updated Date: Mar 16, 2017 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - March 16, 2017 Category: Drugs & Pharmacology Source Type: news

TRIUMEQ (Abacavir Sulfate, Dolutegravir Sodium, Lamivudine) Tablet, Film Coated [A-S Medication Solutions]
Updated Date: Oct 6, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - October 6, 2016 Category: Drugs & Pharmacology Source Type: news

ABACAVIR AND LAMIVUDINE (Abacavir Sulfate And Lamivudine) Tablet, Film Coated [Prasco Laboratories]
Updated Date: Sep 30, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - September 30, 2016 Category: Drugs & Pharmacology Source Type: news

EPZICOM (Abacavir Sulfate And Lamivudine) Tablet, Film Coated [A-S Medication Solutions]
Updated Date: Sep 6, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - September 6, 2016 Category: Drugs & Pharmacology Source Type: news

​ Lupin looks to launch 25 products in US this fiscal
In the current year, apart from the Gavis portfolio, Fortamet and Glumetza, the company expects to launch products like Minastrin and Epzicom. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 15, 2016 Category: Pharmaceuticals Source Type: news

ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE Tablet [LUPIN LIMITED]
Updated Date: May 24, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - May 24, 2016 Category: Drugs & Pharmacology Source Type: news

EPZICOM (Abacavir Sulfate And Lamivudine) Tablet, Film Coated [A-S Medication Solutions]
Updated Date: May 2, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - May 2, 2016 Category: Drugs & Pharmacology Source Type: news

TRIUMEQ (Abacavir Sulfate, Dolutegravir Sodium, Lamivudine) Tablet, Film Coated [A-S Medication Solutions]
Updated Date: Mar 29, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - March 29, 2016 Category: Drugs & Pharmacology Source Type: news

TRIUMEQ (Abacavir Sulfate, Dolutegravir Sodium, Lamivudine) Tablet, Film Coated [ViiV Healthcare Company]
Updated Date: Oct 9, 2015 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - October 9, 2015 Category: Drugs & Pharmacology Source Type: news

FDA Updates Abacavir and Lamivudine Labeling
"On March 23, 2015, FDA approved revisions to the Epivir (lamivudine) and Ziagen (abacavir sulfate) labels to each provide for once-daily dosing in pediatric patients 3 months of age and older in combination with other antiretroviral agents for the treatment of HIV-1 infection."   The updated labeling for both drugs will be available soon at the FDA website.   More information is available:  FDA: Press release AIDSinfo: Patient fact sheet on abacavir AIDSinfo: Patient fact sheet on lamivudine (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research,...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - March 27, 2015 Category: Infectious Diseases Source Type: news

FDA Approves New Fixed-Dose Combination Drug, Triumeq (Abacavir Sulfate/Dolutegravir/Lamivudine), to Treat HIV Infection
"On August 22, 2014, FDA approved a new fixed-dose combination product: TRIUMEQ, a combination of dolutegravir (integrase strand transfer inhibitor), abacavir sulfate and lamivudine (both nucleoside analogue reverse transcriptase inhibitors) for the treatment of HIV-1 infection.  "TRIUMEQ alone is not recommended for use in patients with current or past history of resistance to any components of TRIUMEQ. "TRIUMEQ alone is not recommended in patients with resistance-associated integrase substitutions or clinically suspected integrase strand transfer inhibitor resistance because the dose of dolutegra...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 29, 2014 Category: Infectious Diseases Source Type: news

TRIUMEQ (Dolutegravir Sodium, Abacavir Sulfate, Lamivudine) Tablet, Film Coated [ViiV Healthcare Company]
Updated Date: Aug 26, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - August 26, 2014 Category: Drugs & Pharmacology Source Type: news

TRIZIVIR (Abacavir Sulfate, Lamivudine, And Zidovudine) Tablet, Film Coated [State Of Florida DOH Central Pharmacy]
Updated Date: Apr 28, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - April 28, 2014 Category: Drugs & Pharmacology Source Type: news

ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE Tablet [Lupin Pharmaceuticals, Inc.]
Updated Date: Dec 18, 2013 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - December 18, 2013 Category: Drugs & Pharmacology Source Type: news

Update on Patent Ruling on ViiV Healthcare's EPZICOM® and TRIZIVIR®
GSK and ViiV Healthcare confirmed today that the US District Court for the District of Delaware upheld the validity of a patent covering the double combination of lamivudine and abacavir (Epzicom®) and the triple combination of lamivudine, abacavir and zidovudine (Trizivir®). (Source: GSK news)
Source: GSK news - December 18, 2013 Category: Pharmaceuticals Source Type: news

Switch From Epzicom to Truvada Maintains HIV Suppression: StudySwitch From Epzicom to Truvada Maintains HIV Suppression: Study
Virologic suppression was maintained when HIV patients switched from lamivudine/abacavir (ABC/3TC) to emtricitibine/tenofovir (FTC/TDF) in the pharma-funded SWIFT study. Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 4, 2013 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news